Ruiqing Ni - Publications

Affiliations: 
Eidgenössische Technische Hochschule Zürich, Zürich, ZH, Switzerland 
 Karolinska Institute, Stockholm, Sweden 
Area:
Alzheimer's disease. PET, MRI, Photoacoustics, Neuroimaging; Diagnosis

43 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Kecheliev V, Boss L, Maheshwari U, Konietzko U, Keller A, Razansky D, Nitsch RM, Klohs J, Ni R. Aquaporin 4 is differentially increased and dislocated in association with tau and amyloid-beta. Life Sciences. 321: 121593. PMID 36934970 DOI: 10.1016/j.lfs.2023.121593  0.348
2022 Kecheliev V, Spinelli F, Herde A, Haider A, Mu L, Klohs J, Ametamey SM, Ni R. Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer's disease. Frontiers in Aging Neuroscience. 14: 1018610. PMID 36248003 DOI: 10.3389/fnagi.2022.1018610  0.448
2022 Ren W, Li L, Zhang J, Vaas M, Klohs J, Ripoll J, Wolf M, Ni R, Rudin M. Non-invasive visualization of amyloid-beta deposits in Alzheimer amyloidosis mice using magnetic resonance imaging and fluorescence molecular tomography. Biomedical Optics Express. 13: 3809-3822. PMID 35991935 DOI: 10.1364/BOE.458290  0.427
2022 Ni R, Chen Z, Deán-Ben XL, Voigt FF, Kirschenbaum D, Shi G, Villois A, Zhou Q, Crimi A, Arosio P, Nitsch RM, Nilsson KPR, Aguzzi A, Helmchen F, Klohs J, et al. Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice. Nature Biomedical Engineering. PMID 35835994 DOI: 10.1038/s41551-022-00906-1  0.46
2022 Maschio C, Ni R. Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer's Disease and Other Tauopathies. Frontiers in Aging Neuroscience. 14: 838034. PMID 35527737 DOI: 10.3389/fnagi.2022.838034  0.479
2022 Ni R. Magnetic Resonance Imaging in Tauopathy Animal Models. Frontiers in Aging Neuroscience. 13: 791679. PMID 35145392 DOI: 10.3389/fnagi.2021.791679  0.346
2022 Vagenknecht P, Luzgin A, Ono M, Ji B, Higuchi M, Noain D, Maschio CA, Sobek J, Chen Z, Konietzko U, Gerez JA, Riek R, Razansky D, Klohs J, Nitsch RM, ... ... Ni R, et al. Non-invasive imaging of tau-targeted probe uptake by whole brain multi-spectral optoacoustic tomography. European Journal of Nuclear Medicine and Molecular Imaging. PMID 35128565 DOI: 10.1007/s00259-022-05708-w  0.439
2022 Cao L, Kong Y, Ji B, Ren Y, Guan Y, Ni R. Positron Emission Tomography in Animal Models of Tauopathies. Frontiers in Aging Neuroscience. 13: 761913. PMID 35082657 DOI: 10.3389/fnagi.2021.761913  0.415
2022 Zheng Y, Ji B, Chen S, Zhou R, Ni R. The impact of uremic toxins on Alzheimer's disease. Current Alzheimer Research. PMID 35048807 DOI: 10.2174/1567205019666220120113305  0.359
2022 Ni R, Nitsch RM. Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia. Frontiers in Aging Neuroscience. 13: 751897. PMID 35046791 DOI: 10.3389/fnagi.2021.751897  0.389
2021 Ni R. Magnetic Resonance Imaging in Animal Models of Alzheimer's Disease Amyloidosis. International Journal of Molecular Sciences. 22. PMID 34884573 DOI: 10.3390/ijms222312768  0.405
2021 Ni R. Positron Emission Tomography in Animal Models of Alzheimer's Disease Amyloidosis: Translational Implications. Pharmaceuticals (Basel, Switzerland). 14. PMID 34832961 DOI: 10.3390/ph14111179  0.407
2021 Kindler D, Maschio C, Ni R, Zerbi V, Razansky D, Klohs J. Arterial spin labeling demonstrates preserved regional cerebral blood flow in the P301L mouse model of tauopathy. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211062274. PMID 34822744 DOI: 10.1177/0271678X211062274  0.395
2021 Zhou R, Ji B, Kong Y, Qin L, Ren W, Guan Y, Ni R. PET Imaging of Neuroinflammation in Alzheimer's Disease. Frontiers in Immunology. 12: 739130. PMID 34603323 DOI: 10.3389/fimmu.2021.739130  0.381
2021 Ni R, Villois A, Dean-Ben XL, Chen Z, Vaas M, Stavrakis S, Shi G, deMello A, Ran C, Razansky D, Arosio P, Klohs J. and characterization of CRANAD-2 for multi-spectral optoacoustic tomography and fluorescence imaging of amyloid-beta deposits in Alzheimer mice. Photoacoustics. 23: 100285. PMID 34354924 DOI: 10.1016/j.pacs.2021.100285  0.471
2021 Kong Y, Huang L, Li W, Liu X, Zhou Y, Liu C, Zhang S, Xie F, Zhang Z, Jiang D, Zhou W, Ni R, Zhang C, Sun B, Wang J, et al. The Synaptic Vesicle Protein 2A Interacts With Key Pathogenic Factors in Alzheimer's Disease: Implications for Treatment. Frontiers in Cell and Developmental Biology. 9: 609908. PMID 34277597 DOI: 10.3389/fcell.2021.609908  0.362
2021 Ni R, Röjdner J, Voytenko L, Dyrks T, Thiele A, Marutle A, Nordberg A. In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK1195 in Autopsy Alzheimer's Brain Tissue. Journal of Alzheimer's Disease : Jad. PMID 33749648 DOI: 10.3233/JAD-201344  0.597
2021 Razansky D, Klohs J, Ni R. Multi-scale optoacoustic molecular imaging of brain diseases. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33594473 DOI: 10.1007/s00259-021-05207-4  0.311
2020 Ni R, Chen Z, Gerez JA, Shi G, Zhou Q, Riek R, Nilsson KPR, Razansky D, Klohs J. Detection of cerebral tauopathy in P301L mice using high-resolution large-field multifocal illumination fluorescence microscopy. Biomedical Optics Express. 11: 4989-5002. PMID 33014595 DOI: 10.1364/Boe.395803  0.368
2020 Ni R, Zarb Y, Kuhn GA, Müller R, Yundung Y, Nitsch RM, Kulic L, Keller A, Klohs J. SWI and phase imaging reveal intracranial calcifications in the P301L mouse model of human tauopathy. Magma (New York, N.Y.). PMID 32468149 DOI: 10.1007/S10334-020-00855-3  0.44
2019 Ren W, Skulason H, Schlegel F, Rudin M, Klohs J, Ni R. Automated registration of magnetic resonance imaging and optoacoustic tomography data for experimental studies. Neurophotonics. 6: 025001. PMID 30989087 DOI: 10.1117/1.Nph.6.2.025001  0.303
2019 Ni R, Kindler DR, Waag R, Rouault M, Ravikumar P, Nitsch R, Rudin M, Camici GG, Liberale L, Kulic L, Klohs J. fMRI Reveals Mitigation of Cerebrovascular Dysfunction by Bradykinin Receptors 1 and 2 Inhibitor Noscapine in a Mouse Model of Cerebral Amyloidosis. Frontiers in Aging Neuroscience. 11: 27. PMID 30890928 DOI: 10.3389/Fnagi.2019.00027  0.478
2018 Ni R, Mu L, Ametamey S. Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system. Acta Pharmacologica Sinica. PMID 29921889 DOI: 10.1038/S41401-018-0035-5  0.406
2018 Ni R, Rudin M, Klohs J. Cortical hypoperfusion and reduced cerebral metabolic rate of oxygen in the arcAβ mouse model of Alzheimer's disease. Photoacoustics. 10: 38-47. PMID 29682448 DOI: 10.1016/J.Pacs.2018.04.001  0.364
2018 Ni R, Ji B, Ono M, Sahara N, Zhang MR, Aoki I, Nordberg A, Suhara T, Higuchi M. Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29419480 DOI: 10.2967/Jnumed.117.201632  0.6
2018 Ishikawa A, Tokunaga M, Maeda J, Minamihisamatsu T, Shimojo M, Takuwa H, Ono M, Ni R, Hirano S, Kuwabara S, Ji B, Zhang MR, Aoki I, Suhara T, Higuchi M, et al. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510. Journal of Alzheimer's Disease : Jad. 61: 1037-1052. PMID 29332041 DOI: 10.3233/Jad-170509  0.468
2018 Ni R, Haider A, Herde A, Klohs J, Mu L, Ametamey SM. P4-311: Evaluation Of Cannabinoid Receptor 2 Pet Imaging Tracers In Alzheimer'S Disease Brain Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.07.134  0.499
2018 Ni R, Vaas M, Arosio P, Klohs J. O5-01-01: IN VIVO OPTOACOUSTIC TOMOGRAPHY OF BRAIN AMYLOID DEPOSITS IN AN ARCAβ MOUSE MODEL OF ALZHEIMER'S DISEASE Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2995  0.514
2018 Ni R, Kindler DR, Rouault M, Ielacqua GD, Klohs J. P3-063: BRADYKININ ANTAGONIST NOSCAPINE MITIGATES CEREBROVASCULAR DYSFUNCTION IN THE ARCAβ MOUSE MODEL OF ALZHEIMER'S DISEASE Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1419  0.441
2017 Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, Dickson DW, Trojanowski JQ, Lee VM, Yoshida M, Hozumi I, Yoshiyama Y, van Swieten JC, Nordberg A, Suhara T, et al. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies. Brain : a Journal of Neurology. PMID 28087578 DOI: 10.1093/Brain/Aww339  0.588
2016 Ni R, Gillberg PG, Bogdanovic N, Viitanen M, Myllykangas L, Nennesmo I, Långström B, Nordberg A. Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27693181 DOI: 10.1016/J.Jalz.2016.08.006  0.618
2016 Ni R, Ji B, Ono M, Sahara N, Aoki I, Zhang M, Suhara T, Higuchi M. Radioligand Binding Assays For Comparison Of Tau Pet Probes, Pbb3 And T807, In Detection Of Tau Pathologies In Alzheimer'S Disease And Psp Brains, And Neurotoxic Tau Species In A Transgenic Mouse Model Alzheimers & Dementia. 12: 725. DOI: 10.1016/J.Jalz.2016.06.1426  0.528
2015 Rodriguez-Vieitez E, Ni R, Gulyás B, Tóth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1119-32. PMID 25893384 DOI: 10.1007/S00259-015-3047-0  0.6
2015 Ni R, Gillberg P, Viitanen M, Myllykangas L, Bogdanovic N, Nennesmo I, Långström B, Nordberg A. P4-254: Characterization of regional binding of clinical amyloid tracers in autosomal dominant and sporadic Alzheimer's disease brains and their interactions with resveratrol Alzheimer's & Dementia. 11: P878-P878. DOI: 10.1016/J.Jalz.2015.08.083  0.602
2014 Ni R, Rodriguez-Vieitez E, Voytenko L, Marutle A, Nordberg A. Different Time Course Of Astrocytosis And Amyloid Deposition In Alzheimer'S Appswe Transgenice Mice: A Multi-Tracer Micropet Study Alzheimers & Dementia. 10: 253. DOI: 10.1016/J.Jalz.2014.04.394  0.578
2013 Marutle A, Gillberg PG, Bergfors A, Yu W, Ni R, Nennesmo I, Voytenko L, Nordberg A. ³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain. Journal of Neuroinflammation. 10: 90. PMID 23880036 DOI: 10.1186/1742-2094-10-90  0.648
2013 Ni R, Gillberg PG, Bergfors A, Marutle A, Nordberg A. Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue. Brain : a Journal of Neurology. 136: 2217-27. PMID 23757761 DOI: 10.1093/Brain/Awt142  0.565
2013 Choo IH, Ni R, Schöll M, Wall A, Almkvist O, Nordberg A. Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients. Journal of Alzheimer's Disease : Jad. 33: 929-39. PMID 23047371 DOI: 10.3233/Jad-2012-121489  0.537
2013 Ni R, Marutle A, Nordberg A. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain. Journal of Alzheimer's Disease : Jad. 33: 841-51. PMID 23042213 DOI: 10.3233/Jad-2012-121447  0.603
2013 Rodriguez-Vieitez E, Ni R, Gulyás B, Toth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A. Astrocytosis precedes amyloid deposition in Alzheimer’s disease Tg2576 APPswe transgenic mice: A multitracer microPET imaging study Alzheimers & Dementia. 9: 337. DOI: 10.1016/J.Jalz.2013.04.197  0.563
2011 Thomé C, Ni R, Gillberg P, Marutle A, Nordberg A. P4-301: Evolution of fibrillar amyloid in relation to astro- and microgliosis and alterations in α7 nicotinic receptors in Alzheimer APPswe mice as studied with multi-tracer concept Alzheimer's & Dementia. 7: e16-e17. DOI: 10.1016/J.Jalz.2011.09.046  0.545
2011 Ni R, Marutle A, Nordberg A. P2-487: Alpha7 nicotinic receptor agonists interrupt the interaction between fibrillar amyloid and nicotinic receptor in Alzheimer's brain Alzheimer's & Dementia. 7: S468-S468. DOI: 10.1016/J.Jalz.2011.05.1358  0.512
2011 Marutle A, Bergfors A, Ni R, Nennesmo I, Gillberg P, Nordberg A. P2-329: Laminar distributions of fibrillar β-amyloid and activated astrocytes in Alzheimer's disease autopsy brain: A quantitative autoradiography study Alzheimer's & Dementia. 7: S414-S415. DOI: 10.1016/J.Jalz.2011.05.1205  0.593
Show low-probability matches.